A comparison of atenolol, labetalol, esmolol, and landiolol for altering human neutrophil functions.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 11524332.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Neutrophils play a pivotal role in the antibacterial host defense system. Atenolol, labetalol, esmolol, and landiolol at clinically relevant concentrations failed to change neutrophil functions. Our findings indicate that we may be able to use these beta-antagonists without great caution in clinical settings.
Medical subject headings
- Adrenergic beta-Antagonists
- Neutrophils